0002042485-25-000006.txt : 20251009 0002042485-25-000006.hdr.sgml : 20251009 20251009114823 ACCESSION NUMBER: 0002042485-25-000006 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251009 DATE AS OF CHANGE: 20251009 EFFECTIVENESS DATE: 20251009 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EyeMacular Regeneration, Inc. CENTRAL INDEX KEY: 0002042485 ORGANIZATION NAME: EIN: 934723661 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-527741 FILM NUMBER: 251384015 BUSINESS ADDRESS: STREET 1: 202 4TH ST SW STREET 2: SUITE 160 CITY: ROCHESTER STATE: MN ZIP: 55902 BUSINESS PHONE: 404-290-6418 MAIL ADDRESS: STREET 1: 202 4TH ST SW STREET 2: SUITE 160 CITY: ROCHESTER STATE: MN ZIP: 55902 D/A 1 primary_doc.xml X0708 D/A LIVE 0002042485 EyeMacular Regeneration, Inc. 1000 Westgate Dr. STE 113 St. Paul MN MINNESOTA 55114 404-290-6418 DELAWARE None None Corporation true 2023 Timothy W Olsen 1000 Westgate Dr. STE 113 St. Paul MN MINNESOTA 55114 Executive Officer Director Dr. Olsen is the Chief Executive Officer and Chair of the Board of Directors. Virginia Olsen 900 12th Ave SW Rochester MN MINNESOTA 55902-2072 Executive Officer Virginia Olsen is Secretary and Chief Human Capital Officer Gerald R. Benjamin 88 West Paces Ferry Rd Atlanta GA GEORGIA 30305 Director Mr. Benjamin serves on the Board of Directors Richard L. Lindstrom 2811 Westwood Rd S. Wayzata MN MINNESOTA 55391-9787 Director Dr. Lindstrom serves on the Board of Directors David M. Brown 4707 FM 1697 Road Burton TX TEXAS 77835 Director Dr. Brown serves on the Board of Directors Michael Lindsay Olsen 9445 Rosewood Dr. Unit 3A Prairie Village KS KANSAS 66207 Director Mr. Olsen serves on the Board of Directors Biotechnology No Revenues 06b true 0002042485-24-000001 2024-10-08 true true false 100000 6000000 2000000 4000000 false 12 0 0 0 All officers and directors are foregoing receipt of compensation for his services in order to utilize the gross proceeds for continuing research and development of the medical technology. false EyeMacular Regeneration, Inc. Timothy W. Olsen Timothy W. Olsen, M.D. CEO 2025-10-09